ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 862

Discriminative Performance of Nasal Endoscopic Findings and History Items in Patients with Granulomatosis with Polyangiitis

Erdem Eren1, Toygar Kalkan2, Secil Arslanoglu1, Mustafa Ozmen3, Kazim Onal1, Emine Figen Tarhan3 and Servet Akar4, 1Head and Neck Surgery, Izmir Ataturk Research and Training Hospital, Izmir, Turkey, 2Internal Medicine, Izmir Ataturk Research and Training Hospital, Izmir, Turkey, 3Rheumatology, Izmir Ataturk Research and Training Hospital, Izmir, Turkey, 4Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Examination, Wegener's granulomatosis and diagnosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Vasculitis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Granulomatosis with polyangiitis (Wegener’s granulomatosis, GPA) is a systemic vasculitis of unknown etiology. It is characterized by necrotizing granulomatous inflammation and affects predominantly small vessels. Upper respiratory tract is involved in some phase of the disease in about 90% of the patients and most frequently at the beginning of the disease. Median diagnostic delay was reported as 4-17 months and it was most remarkable in patients with head and neck symptoms. Up to now clinical manifestations of GPA were described retrospectively and discriminative ability of nasal history and examination findings was never systematically evaluated before. Therefore we aimed to determine the predictive value of history items and nasal endoscopic examination findings in the diagnosis of GPA. 

Methods: Seventeen GPA patients (12 [67%] male; mean age 49,3 ± 13,9), 29 patients with rheumatologic disease other than GPA (8 [28%] male; mean age 46.8 ± 16.3) and 67 healthy subjects (28 [42%] male; mean age 47,3 ± 15,2) were included in the study. Patients’ history was taken by a physician blinded to diagnosis and each patient was examined with flexible nasal endoscope and nasal endoscopic images are recorded and evaluated blindly. The following history items were noted and graded as present or absent; sneezing, rhinorrhea, nasal obstruction, cough, postnasal drip, facial pain, taste disturbance, decreased smell, epiphora, epistaxis, saddle-nose. Nasal endoscopic findings noted were edema of middle meatus, nasal secretion, polypoid changes of middle meatus mucosa, nasal polyposis, hypertrophy of inferior turbinate, septal perforation, nasal crusting, adhesions, granuloma, hemorrhagic fragile nasal mucosa.  

Results: Regarding the history items univariate analysis revealed that rhinorrhea (p=0,003), postnasal drip (p=0,022), epistaxis (p<0,001), and saddle nose deformity (p=0,046) were statistically significantly different between groups. However in binary logistic regression analysis none of these history items have a statistically significant predictive role in selecting patients with GPA. A univariate analysis demonstrates that the following endoscopic findings demonstrates statistically significant difference; nasal secretion (p=0,003), nasal septal perforation (p < 0,001), nasal crusting (p< 0,001), nasal adhesion (p < 0,001), nasal granuloma (p=0,046), polypoid changes of middle meatus mucosa (p=0,42), and hemorrhagic fragile nasal mucosa (p < 0,001). In regression analysis hemorrhagic fragile nasal mucosa (p< 0,001, OR=41) was the only significant predictor for GPA.  

Conclusion: The results of the present study suggest that patients with hemorrhagic fragile nasal mucosa should alert the physician about the possibility of GPA. The role of the other nasal mucosal findings in the differential diagnosis of GPA needs to be verified by larger studies.


Disclosure: E. Eren, None; T. Kalkan, None; S. Arslanoglu, None; M. Ozmen, None; K. Onal, None; E. F. Tarhan, None; S. Akar, None.

To cite this abstract in AMA style:

Eren E, Kalkan T, Arslanoglu S, Ozmen M, Onal K, Tarhan EF, Akar S. Discriminative Performance of Nasal Endoscopic Findings and History Items in Patients with Granulomatosis with Polyangiitis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/discriminative-performance-of-nasal-endoscopic-findings-and-history-items-in-patients-with-granulomatosis-with-polyangiitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/discriminative-performance-of-nasal-endoscopic-findings-and-history-items-in-patients-with-granulomatosis-with-polyangiitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology